Vol 24, No 6 (2019)
Original research articles
Published online: 2019-11-01

open access

Page views 339
Article views/downloads 291
Get Citation

Connect on Social Media

Connect on Social Media

Feasibility study on the use of 230MeV proton cyclotron in proton therapy centers as a spallation neutron source for BNCT

E. Nobakht, N. Fouladi1
DOI: 10.1016/j.rpor.2019.10.005
Rep Pract Oncol Radiother 2019;24(6):644-653.

Abstract

Aim

The feasibility of using 230MeV proton cyclotrons in proton therapy centers as a spallation neutron source for Boron Neutron Capture Therapy (BNCT) was investigated.

Background

BNCT is based on the neutron irradiation of a 10B-containing compound located selectively in tumor cells. Among various types of neutron generators, the spallation neutron source is a unique way to generate high-energy and high-flux neutrons.

Materials and Methods

Neutron beam was generated by a proton accelerator via spallation reactions and then the produced neutron beam was shaped to be appropriate for BNCT. The proposed Beam Shaping Assembly (BSA) consists of different moderators, a reflector, a collimator, as well as thermal and gamma filters. In addition, the simulated Snyder head phantom was utilized to evaluate the dose distribution in tumor and normal tissue due to the irradiation by the designed beam. MCNPX2.6 Monte Carlo code was used to optimize BSA as well as evaluate dose evaluation.

Results

A BSA was designed. With the BSA configuration and a beam current of 104nA, epithermal neutron flux of 3.94×106 [n/cm2] can be achieved, which is very low. Provided that we use the beam current of 5.75μA, epithermal neutron flux of 2.18×108 [n/cm2] can be obtained and the maximum dose of 38.2 Gy-eq can be delivered to tumor tissue at 1.4cm from the phantom surface.

Conclusions

Results for 230MeV protons show that with proposed BSA, proton beam current about 5.75μA is required for this purpose.

Article available in PDF format

View PDF Download PDF file